Evidence map›Paper›PMID 32483864›Full record

ArticleProtein science : a publication of the Protein Society2020

Discriminating changes in protein structure using tyrosine conjugation.

Mahta Moinpour, Natalie K Barker, Lindsay E Guzman, John C Jewett, Paul R Langlais, Jacob C Schwartz

Open access · greenAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy.Colloids and surfaces. B, Biointerfaces · 2021
    Article
  10. Article
  11. Article
  12. Discriminating changes in protein structure using tyrosine conjugation.Protein science : a publication of the Protein Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mahta MoinpourDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, USA.
Natalie K BarkerDepartment of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona, USA.
Lindsay E GuzmanDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, USA.
John C JewettDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, USA.
Paul R LanglaisDepartment of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson, Arizona, USA.
Jacob C SchwartzDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, USA.ORCID 0000-0002-5205-564X
University of Arizona · US

Funding

Analysis of the RNA-binding Protein FUS and Its Role in Neurodegenerative DiseaseR00NS082376 · NINDS · UNIVERSITY OF ARIZONA · PI SCHWARTZ, JACOB C. · 2015 to 2017
$771k
Ewing sarcoma: fusion protein structure/function relationships that reprogram transcriptionR21CA238499 · NCI · UNIVERSITY OF ARIZONA · PI SCHWARTZ, JACOB C. · 2019 to 2020
$393k
Analysis of the RNA-binding Protein FUS and Its Role in Neurodegenerative DiseaseK99NS082376 · NINDS · UNIVERSITY OF COLORADO · PI SCHWARTZ, JACOB C. · 2013 to 2014
$192k
Radiation and Fluorescence Imaging Technology for Biology and BiochemistryS10OD013237 · OD · UNIVERSITY OF ARIZONA · PI PARK, CHAD KING · 2013 to 2013
$137k
NCI NIH HHS R21 CA238499NIH HHS R21CA238499NIH HHS S10 OD013237NIH HHS S10OD013237NINDS NIH HHS NS082376NINDS NIH HHS R00 NS082376
6 · The paper itself

Abstract

Chemical modification of proteins has been crucial in engineering protein-based therapies, targeted biopharmaceutics, molecular probes, and biomaterials. Here, we explore the use of a conjugation-based approach to sense alternative conformational states in proteins. Tyrosine has both hydrophobic and hydrophilic qualities, thus allowing it to be positioned at protein surfaces, or binding interfaces, or to be buried within a protein. Tyrosine can be conjugated with 4-phenyl-3H-1,2,4-triazole-3,5(4H)-dione (PTAD). We hypothesized that individual protein conformations could be distinguished by labeling tyrosine residues in the protein with PTAD. We conjugated tyrosine residues in a well-folded protein, bovine serum albumin (BSA), and quantified labeled tyrosine with liquid chromatography with tandem mass spectrometry. We applied this approach to alternative conformations of BSA produced in the presence of urea. The amount of PTAD labeling was found to relate to the depth of each tyrosine relative to the protein surface. This study demonstrates a new use of tyrosine conjugation using PTAD as an analytic tool able to distinguish the conformational states of a protein.

Indexed as

AnimalsCattleChromatography, LiquidProtein DomainsSerum Albumin, BovineTandem Mass SpectrometryTriazolesTyrosine4-phenyl-1,2,4-triazoline-3,5-dioneSerum Albumin, BovineTriazolesTyrosineconjugationlow complexityprotein foldingtriazolinedionestyrosine

Identifiers

PMID32483864
PMCPMC7380675
OpenAlexW3032697749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.